Older adults' adherence to medications and willingness to deprescribe: A substudy of a randomized clinical trial DOI Creative Commons
Kristie Rebecca Weir, Katharina Tabea Jungo, Sven Streit

и другие.

British Journal of Clinical Pharmacology, Год журнала: 2023, Номер 90(3), С. 905 - 911

Опубликована: Ноя. 13, 2023

Our study investigated the association between patients' willingness to have medications deprescribed and medication adherence. This longitudinal substudy of 'Optimizing PharmacoTherapy In Multimorbid Elderly in Primary CAre' (OPTICA) trial, a cluster randomized controlled took place Swiss primary care settings. Participants were aged ≥65 years over, with ≥3 chronic conditions ≥5 regular medications. At baseline, 'revised Patient Attitudes Towards Deprescribing' (rPATD) questionnaire was measured. The A14-scale measured adherence (self-report) at 12-month follow-up. Multilevel linear regression analyses adjusted for baseline variables performed. Of 298 participants, 45% women, median age 78. reported high level deprescribed. We did not find evidence an deprescribe Further research is needed explore relationship these concepts inform collaborative decisions about medicines context polypharmacy.

Язык: Английский

Older adults' adherence to medications and willingness to deprescribe: A substudy of a randomized clinical trial DOI Creative Commons
Kristie Rebecca Weir, Katharina Tabea Jungo, Sven Streit

и другие.

British Journal of Clinical Pharmacology, Год журнала: 2023, Номер 90(3), С. 905 - 911

Опубликована: Ноя. 13, 2023

Our study investigated the association between patients' willingness to have medications deprescribed and medication adherence. This longitudinal substudy of 'Optimizing PharmacoTherapy In Multimorbid Elderly in Primary CAre' (OPTICA) trial, a cluster randomized controlled took place Swiss primary care settings. Participants were aged ≥65 years over, with ≥3 chronic conditions ≥5 regular medications. At baseline, 'revised Patient Attitudes Towards Deprescribing' (rPATD) questionnaire was measured. The A14-scale measured adherence (self-report) at 12-month follow-up. Multilevel linear regression analyses adjusted for baseline variables performed. Of 298 participants, 45% women, median age 78. reported high level deprescribed. We did not find evidence an deprescribe Further research is needed explore relationship these concepts inform collaborative decisions about medicines context polypharmacy.

Язык: Английский

Процитировано

0